Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioanalysis|August 5, 2024
The European Bioanalysis Forum recommendation on establishing appropriate drug tolerance levels in antidrug antibody assaysKyra J Cowan, Lysie Champion, Daniel Dyer, et al.
Allergy, Asthma & Immunology Research|July 2, 2021
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous UrticariaPavel Kolkhir, Sabine Altrichter, Riccardo Asero, et al.
Mabs|March 5, 2024
Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Daniel Baltrunkonis, Sofie Denies, et al.
The AAPS Journal|May 13, 2022
When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity PlatformGregor P Lotz, Karin Benstein, Karien Bloem, et al.
Allergy|June 23, 2019
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST StudyNicole Schoepke, Riccardo Asero, André Ellrich, et al.
Frontiers in Immunology|June 6, 2025
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity PlatformJoanna Grudzinska-Goebel, Karin Benstein, Karien Bloem, et al.
Mabs|April 4, 2025
Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Karien Bloem, Lysie Champion, et al.
Bioanalysis|February 3, 2021
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3 - Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)Bart Corsaro, Tong-Yuan Yang, Rocio Murphy, et al.
Pageof 5